Skip to main content
OpenTrials

Clinical trial condition

Metastatic Castration Resistant Prostate Cancer

Explore clinical trials studying Metastatic Castration Resistant Prostate Cancer. Study availability and eligibility vary by location and protocol.

35 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Castration Resistant Prostate Cancer trial results

Completed

Immunotherapy in Patients With Metastatic Cancers and CDK12 Mutations

NCT03570619

Conditions
Metastatic Cancer, Metastatic Castration Resistant Prostate Cancer, Neoplasm Metastasis, +5 more
Locations
  • University of California San Diego, Moores Cancer Center San Diego, California, United States
  • University of California San Francisco/Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • H. Lee. Moffitt Cancer Center & Research Institute, Inc. Tampa, Florida, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
View Trial Details
Completed

A Study to Assess the Benefit of Treatment Beyond Progression With Enzalutamide in Men Who Are Starting Treatment With Docetaxel After Worsening of Their Prostate Cancer When Taking Enzalutamide Alone

NCT02288247

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +12 more
Locations
  • Site AT43004 Linz, Austria
  • Site AT43001 Vienna, Austria
  • Site BE32003 Bonheiden, Belgium
  • Site BE32002 Liège, Belgium
View all 89 locations
View Trial Details
Completed

Study of TAS3681 in Metastatic Castration Resistant Prostate Cancer

NCT02566772

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Univeristy of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Florida Cancer Specialists & Research Institute Sarasota, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States
View all 33 locations
View Trial Details
Completed

CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers

NCT03454451

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +78 more
Locations
  • Arizona Oncology Tucson, Arizona, United States
  • City Of Hope Duarte, California, United States
  • UC San Francisco San Francisco, California, United States
  • Yale School of Medicine New Haven, Connecticut, United States
View all 27 locations
View Trial Details

Related conditions